(MRNA) Moderna - Performance -75.4% in 12m
Compare MRNA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-51.88%
#75 in Group
Rel. Strength
4.52%
#7640 in Universe
Total Return 12m
-75.40%
#152 in Group
Total Return 5y
-44.77%
#58 in Group
P/E -
(?) Percentile in Group
P/E Forward 32.5
79th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -46.42%
(?) Percentile in Group
12m Total Return: MRNA (-75.4%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: MRNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MRNA
Total Return (including Dividends) | MRNA | XBI | S&P 500 |
---|---|---|---|
1 Month | -22.33% | -10.94% | -6.73% |
3 Months | -37.39% | -14.92% | -11.93% |
12 Months | -75.40% | -6.46% | 7.24% |
5 Years | -44.77% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | MRNA | XBI | S&P 500 |
1 Month | -64.0% | -52.8% | -63.5% |
3 Months | -76.3% | -92.8% | -90.3% |
12 Months | -96.7% | -32.4% | 60.6% |
5 Years | -38.2% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #158 | -12.8% | -16.7% |
3 Month | #147 | -26.4% | -28.9% |
12 Month | #152 | -73.7% | -77.1% |
5 Years | #57 | -31.6% | -72.5% |
FAQs
Does MRNA Moderna outperforms the market?
No,
over the last 12 months MRNA made -75.40%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months MRNA made -37.39%, while XBI made -14.92%.
Over the last 3 months MRNA made -37.39%, while XBI made -14.92%.
Performance Comparison MRNA vs Indeces and Sectors
MRNA vs. Indices MRNA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 3.50% | -15.6% | -43.5% | -82.6% |
US NASDAQ 100 | QQQ | 3.02% | -15.0% | -43.7% | -83.0% |
US Dow Jones Industrial 30 | DIA | 5.53% | -15.4% | -44.1% | -79.9% |
German DAX 40 | DAX | 2.28% | -18.4% | -63.4% | -95.7% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.07% | -18.9% | -44.7% | -84.6% |
Hongkong Hang Seng | HSI | 0.83% | -18.6% | -48.1% | -92.2% |
India NIFTY 50 | INDA | 1.35% | -24.4% | -46.9% | -78.4% |
Brasil Bovespa | EWZ | -0.77% | -22.8% | -48.6% | -66.7% |
MRNA vs. Sectors MRNA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 2.79% | -15.5% | -52.7% | -90.5% |
Consumer Discretionary | XLY | 2.06% | -15.5% | -48.8% | -86.7% |
Consumer Staples | XLP | 3.35% | -25.3% | -51.5% | -86.7% |
Energy | XLE | 3.43% | -9.83% | -42.2% | -62.7% |
Financial | XLF | 2.80% | -17.5% | -52.4% | -93.2% |
Health Care | XLV | 5.77% | -14.6% | -41.3% | -73.0% |
Industrial | XLI | 4.10% | -16.3% | -43.4% | -79.5% |
Materials | XLB | 3.76% | -16.5% | -36.3% | -69.5% |
Real Estate | XLRE | 3.73% | -19.1% | -43.2% | -90.1% |
Technology | XLK | 3.23% | -13.3% | -37.3% | -76.6% |
Utilities | XLU | 3.61% | -22.5% | -47.2% | -97.1% |
Aerospace & Defense | XAR | 4.95% | -19.2% | -52.9% | -97.3% |
Biotech | XBI | 0.08% | -11.4% | -32.1% | -68.9% |
Homebuilder | XHB | 1.97% | -14.2% | -28.8% | -64.9% |
Retail | XRT | 1.63% | -16.9% | -40.1% | -69.1% |